Aortic Valve Replacement for Low-Flow/Low-Gradient Aortic StenosisOperative Risk Stratification and Long-Term Outcome: A European Multicenter Study
Franck Levy, MD*,
Marcel Laurent, MD ,
Jean Luc Monin, MD ,
Jean Michel Maillet, MD ,
Agnès Pasquet, MD||,
Thierry Le Tourneau, MD¶,
Hélène Petit-Eisenmann, MD#,
Mauro Gori, MD**,
Yannick Jobic, MD ,
Fabrice Bauer, MD ,
Christophe Chauvel, MD ,
Alain Leguerrier, MD, PhD and
Christophe Tribouilloy, MD, PhD, FACC*,*
* Department of Cardiology, INSERM, ERI-12, University Hospital, Amiens, France
Department of Thoracic and Cardiovascular Surgery, University Hospital, Rennes, France
Department of Cardiology, Henri Mondor Hospital, Créteil, France
Department of Cardiac Surgery, Centre Cardiologique du Nord, Saint Denis, France
|| Department of Cardiology, Clinique Universitaire St. Luc, Brussels, Belgium
¶ Department of Cardiology, University Hospital, Lille, France
# Department of Cardiac Surgery, University Hospital, Strasbourg, France
** Department of Cardiology, Ospedali Riuniti, Bergamo, Italy
 Department of Cardiology, University Hospital, Brest, France
 Department of Cardiology, University Hospital, Rouen, France
 Department of Cardiology, Clinique Saint-Augustin, Bordeaux, France.

View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 5-Year Overall Survival Curves
(A) Patients with and without prior atrial fibrillation, (B) patients with and without multivessel coronary artery disease, (C) patients with mean gradient 20 and >20 mm Hg, and (D) patients with pre-operative European System for Cardiac Operative Risk Evaluation score 10 and >10. AF = atrial fibrillation; MVD = multivessel coronary artery disease.
|
|
|